West Pharmaceutical Services, Inc.
US ˙ NYSE ˙ US9553061055

SecurityWST / West Pharmaceutical Services, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership142,185 shares
Latest Disclosed Value $ 39,120,781
Barclays Plc ownership in WST / West Pharmaceutical Services, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 142,185 shares of West Pharmaceutical Services, Inc. (US:WST) valued at $39,120,781 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 140,016 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of 1.55% during the quarter. The current value of the position is $44,974,537 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (WST) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 50,000 of underlying shares valued at $13,757,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

WST / West Pharmaceutical Services, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 142,185 2,169 1.55 39,121 6.51 0.0094
2026-03-31 2025-09-30 13F/A-3 WEST PHARMACEUTICAL SVSC COM 955306105 140,016 -59,572 -29.85 36,730 -15.89 0.0080
2026-03-19 2025-09-30 13F/A-2 WEST PHARMACEUTICAL SVSC COM 955306105 255,185 55,597 76,596 0.0203
2025-11-12 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 140,016 -59,572 36,730 0.0080
2026-02-27 2025-06-30 13F/A-2 WEST PHARMACEUTICAL SVSC COM 955306105 199,588 7,412 3.86 43,670 1.50 0.0100
2025-08-14 2025-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 199,588 7,412 44 0.0100
2025-08-13 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 199,588 7,412 44 0.0033
2026-03-17 2025-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 192,176 51,044 36.17 43,024 -6.93 0.0122
2025-05-15 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 192,176 51,044 43 0.0122
2026-03-19 2024-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 141,132 -114,053 -44.69 46,229 -39.65 0.0130
2025-02-13 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 141,132 -114,053 46 0.0130
2026-03-31 2024-09-30 13F/A-2 WEST PHARMACEUTICAL SVSC COM 955306105 255,185 83,710 48.82 76,596 35.61 0.0203
2024-11-19 2024-09-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 255,185 83,710 77 0.0203
2024-11-15 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 255,185 83,710 77 0.0062
2026-03-23 2024-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 171,475 20,815 13.82 56,482 -5.26 0.0173
2024-08-14 2024-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 171,475 20,815 56 0.0173
2026-03-24 2024-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 150,660 -25,556 -14.50 59,618 -3.92 0.0207
2024-05-15 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 150,660 -25,556 60 0.0207
2026-03-25 2023-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 176,216 18,220 11.53 62,049 4.67 0.0228
2024-02-15 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 176,216 18,220 62 0.0228
2026-03-26 2023-09-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 157,996 27,264 20.85 59,282 18.56 0.0369
2023-11-07 2023-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 157,996 27,264 59 0.0369
2026-03-30 2023-06-30 13F/A-2 WEST PHARMACEUTICAL SVSC COM 955306105 130,732 60,041 84.93 50,001 104.15 0.0317
2023-09-20 2023-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 130,732 60,041 50 0.0317
2023-08-03 2023-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 130,732 60,041 50 0.0315
2026-03-30 2023-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 70,691 -24,767 -25.95 24,492 9.02 0.0112
2023-05-04 2023-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 70,691 -24,767 24 0.0112
2026-03-30 2022-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 95,458 16,704 21.21 22,466 15.93 0.0101
2023-02-13 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 95,458 16,704 22 0.0101
2022-11-03 2022-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 78,754 689 0.88 19,379 -17.90 0.0211
2022-08-12 2022-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 78,065 -70,684 -47.52 23,605 -61.36 0.0144
2022-05-16 2022-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 148,749 7,575 5.37 61,093 -7.73 0.0479
2022-02-23 2021-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 141,174 25,701 22.26 66,211 35.06 0.0247
2022-02-14 2021-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 141,174 25,701 66,211 0.0075
2021-11-09 2021-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 115,473 -654 -0.56 49,022 17.56 0.0221
2021-08-13 2021-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 116,127 19,099 19.68 41,701 52.53 0.0197
2021-05-13 2021-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 97,028 29,082 42.80 27,340 42.03 0.0147
2021-02-11 2020-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 67,946 6,707 10.95 19,249 14.35 0.0102
2020-11-12 2020-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 61,239 7,762 14.51 16,833 38.54 0.0100
2020-08-12 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 53,477 13,497 33.76 12,150 99.61 0.0094
2020-05-13 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 39,980 -42,691 -51.64 6,087 -51.02 0.0048
2020-02-10 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 82,671 -17,681 -17.62 12,428 -12.67 0.0069
2019-11-15 2019-09-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 100,352 72,629 261.98 14,231 310.23 0.0089
2019-11-14 2019-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 100,352 72,629 14,231 3,290.2233
2019-08-14 2019-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 27,723 -11,026 -28.45 3,469 -18.78 0.0021
2019-05-15 2019-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 38,749 19,498 101.28 4,271 126.34 0.0029
2019-02-14 2018-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 19,251 -6,592 -25.51 1,887 -40.88 0.0015
2018-11-14 2018-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 25,843 20,284 364.89 3,192 477.22 0.0022
2018-08-14 2018-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,559 -24,957 -81.78 553 -79.48 0.0005
2018-05-15 2018-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 30,516 27,709 987.14 2,695 872.92 0.0021
2018-02-14 2017-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,807 1,861 196.72 277 201.09 0.0002
2017-11-14 2017-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 946 -10,252 -91.55 92 -91.30 0.0001
2017-08-14 2017-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 11,198 1,057 10.42 1,058 27.93 0.0011
2017-05-15 2017-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 10,141 2,814 38.41 827 33.17 0.0009
2017-02-14 2016-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 7,327 4,113 127.97 621 159.83 0.0007
2016-11-14 2016-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,214 -18,438 -85.16 239 -85.44 0.0003
2016-08-12 2016-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 21,652 20,874 2,683.03 1,642 2,998.11 0.0021
2016-05-16 2016-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 778 -2,838 -78.48 53 -75.58 0.0001
2016-02-12 2015-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,616 2,387 194.22 217 228.79 0.0003
2015-11-13 2015-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,229 -193 -13.57 66 -20.48 0.0001
2015-08-14 2015-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,422 -739 -34.20 83 -35.66 0.0001
2015-05-19 2015-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 2,161 -3,725 -63.29 129 -58.65 0.0001
2015-05-14 2015-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,161 129
2015-02-13 2014-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,886 -3,260 -35.64 312 -22.39 0.0003
2014-11-14 2014-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 9,146 7,877 620.72 402 644.44 0.0004
2014-08-14 2014-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,269 -1,597 -55.72 54 -56.80 0.0001
2014-05-15 2014-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,866 -63,008 -95.65 125 -96.13 0.0001
2014-02-13 2013-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 65,874 18,016 37.64 3,228 64.53 0.0033
2013-11-14 2013-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 47,858 12,409 35.01 1,962 -21.24 0.0023
2013-08-14 2013-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 35,449 35,449 2,491 0.0031
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-19 2024-09-30 13F/A WEST PHARMACEUTICAL SVSC OPT Call 0 0 n/a n/a n/a
2026-03-31 2024-09-30 13F/A WEST PHARMACEUTICAL SVSC OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-15 2024-09-30 13F WEST PHARMACEUTICAL SVSC OPT Call 0 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A WEST PHARMACEUTICAL SVSC OPT Call 105,500 34,751 n/a n/a n/a
2024-08-14 2024-06-30 13F WEST PHARMACEUTICAL SVSC OPT Call 105,500 35 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F WEST PHARMACEUTICAL SVSC OPT Put 50,000 -67.55 13,757 -70.26 n/a n/a n/a
2026-03-19 2025-09-30 13F/A WEST PHARMACEUTICAL SVSC OPT Put 154,100 46,255 n/a n/a n/a
2026-03-17 2025-03-31 13F/A WEST PHARMACEUTICAL SVSC OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F WEST PHARMACEUTICAL SVSC OPT Put 0 0 n/a n/a n/a
2026-03-19 2024-12-31 13F/A WEST PHARMACEUTICAL SVSC OPT Put 215,000 39.52 70,425 52.26 n/a n/a n/a
2025-02-13 2024-12-31 13F WEST PHARMACEUTICAL SVSC OPT Put 215,000 70 n/a n/a n/a
2024-11-19 2024-09-30 13F/A WEST PHARMACEUTICAL SVSC OPT Put 154,100 46 n/a n/a n/a
2026-03-31 2024-09-30 13F/A WEST PHARMACEUTICAL SVSC OPT Put 154,100 46,255 n/a n/a n/a
2024-11-15 2024-09-30 13F WEST PHARMACEUTICAL SVSC OPT Put 154,100 46 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.